NeuroHarmonics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2M

  • Investors
  • 5

NeuroHarmonics General Information

Description

Developer of a neurotechnology platform designed to non-invasively treat neurological and psychiatric conditions through ultrasound-based brain modulation. The company's platform offers focused ultrasound technology and outpatient treatment devices, enabling healthcare providers to target specific brain circuits and deliver non-surgical neurological therapies.

Contact Information

Website
www.neuroharmonics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 71-75 Shelton Street
  • Covent Garden
  • London WC2H 9JQ
  • England, United Kingdom
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Wearables & Quantified Self, HealthTech
Corporate Office
  • 71-75 Shelton Street
  • Covent Garden
  • London WC2H 9JQ
  • England, United Kingdom

NeuroHarmonics Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroHarmonics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 22-Jan-2026 $2M Completed Product Development
1. Seed Round 20-Dec-2024 Completed Product Development
To view NeuroHarmonics’s complete valuation and funding history, request access »

NeuroHarmonics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference
Preference
Ordinary 5,296 $0.000013 $5.98 $5.98 1x $5.98 0.4%
To view NeuroHarmonics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

NeuroHarmonics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroHarmonics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
AlbionVC Venture Capital Minority
Fusion Fund Venture Capital Minority
Jumpspace Ventures Venture Capital Minority
Speedinvest Venture Capital Minority
UCL Technology Fund Venture Capital Minority
To view NeuroHarmonics’s complete investors history, request access »

Ready to get started?

Request a free trial

NeuroHarmonics FAQs

  • When was NeuroHarmonics founded?

    NeuroHarmonics was founded in 2024.

  • Where is NeuroHarmonics headquartered?

    NeuroHarmonics is headquartered in London, United Kingdom.

  • What is the size of NeuroHarmonics?

    NeuroHarmonics has 11 total employees.

  • What industry is NeuroHarmonics in?

    NeuroHarmonics’s primary industry is Therapeutic Devices.

  • Is NeuroHarmonics a private or public company?

    NeuroHarmonics is a Private company.

  • What is NeuroHarmonics’s current revenue?

    The current revenue for NeuroHarmonics is .

  • How much funding has NeuroHarmonics raised over time?

    NeuroHarmonics has raised $4.07M.

  • Who are NeuroHarmonics’s investors?

    AlbionVC, Fusion Fund, Jumpspace Ventures, Speedinvest, and UCL Technology Fund have invested in NeuroHarmonics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process